Top movers in Friday's session

Last update: Sep 19, 2025

Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

Gainers

Ticker	Change	Comment
ARQQW	90.07%	ARQIT QUANTUM INC -CW26's (NASDAQ:ARQQW) shares rose 90.07% to $0.84. In the last month the stock gained 50.2%.
YAAS	53.77%	Investors celebrated as YOUXIN TECHNOLOGY LTD-CL A (NASDAQ:YAAS) experienced a 53.77% rise in its shares, closing at $0.12 during Friday's session. The stock is trading 79.06% lower than a month ago.
SVIIW	38.89%	SPRING VALLEY ACQUISITION-AW's (NASDAQ:SVIIW) shares rose 38.89% to $1.0. In the last month the stock gained 125.0%.
QMCO	37.08%	QUANTUM CORP's (NASDAQ:QMCO) shares soared 37.08% to $11.58 during Friday's session. A press release (DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Quantum Corporation) was released two days ago.
ZOOZ	28.76%	ZOOZ POWER LTD (NASDAQ:ZOOZ) rose 28.76% to $3.0 during Friday's after hours session. A press release (ZOOZ Shareholders Approve Previously Announced $180 Million Private Placement and Bitcoin Treasury Reserve Strategy, Along with All Related Proposals) was released earlier today.
BHF	27.95%	BRIGHTHOUSE FINANCIAL INC's (NASDAQ:BHF) stock price increased by 27.95% to $57.91. In the last 3 months the stock lost 23.11%.
MVSTW	25.0%	MICROVAST HOLD INC-CW26's (NASDAQ:MVSTW) stock price is advancing with 25.0% to a price of $0.2. In the last 3 months the stock lost 60.97%.
VERI	24.27%	Investors witnessed a remarkable 24.27% rise in VERITONE INC's (NASDAQ:VERI) shares, which climbed to $5.19 during Friday's session. Shareholders saw the stock price going 82.53% higher in the past month.
VRME	24.25%	VERIFYME INC's (NASDAQ:VRME) stock price increased by 24.25% to $1.16. In the last 3 months the share price increased with 25.85%.
QUBT	24.2%	QUANTUM COMPUTING INC (NASDAQ:QUBT) witnessed a notable 24.2% uptick in its shares, reaching $22.79 during Friday's session. The stock is trading 25.51% higher than a month ago.

For the full top gainers list go to our top gainers page.

Top losers

Ticker	Change	Comment
RVPH	-37.12%	There was a notable decline in REVIVA PHARMACEUTICALS HOLDI's (NASDAQ:RVPH) shares, as they dropped 37.12% to $0.26 during Friday's session. In the last 3 months the share price dropped with 40.24%.
HYMCL	-27.78%	During Friday's session, HYCROFT MINING HOLDING -CW25's (NASDAQ:HYMCL) shares took a tumble, falling 27.78% to $0.01. Shareholders saw the stock price going 22.22% lower in the past 3 months.
BREA	-24.62%	There was a notable decline in BRERA HOLDINGS PLC-CL B's (NASDAQ:BREA) shares, as they dropped 24.62% to $18.77 during Friday's session. Earlier today the company had a press release: CryptoNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Rebrands as Solmate After $300 Million PIPE Led by Pulsar Group with Backing from Solana Foundation, ARK Invest, and RockawayX.
FTHM	-17.71%	FATHOM HOLDINGS INC's (NASDAQ:FTHM) stock price faced a 17.71% decline, reaching $1.98 during Friday's session. In the last month the share price increased with 98.35%.
SONN	-16.23%	SONNET BIOTHERAPEUTICS HOLDI's (NASDAQ:SONN) stock price decreased by 16.23% to $6.35. In the last month the share price increased with 135.0%.
SABS	-13.98%	SAB BIOTHERAPEUTICS INC's (NASDAQ:SABS) shares fell 13.98% to $2.4. A press release (SAB BIO Highlights Data in Multiple Presentations at EASD) was released earlier today.
CNFR	-13.06%	CONIFER HOLDINGS INC's (NASDAQ:CNFR) stock price decreased by 13.06% to $1.53. The stock is trading 104.0% higher than a month ago.
AIRE	-13.02%	REALPHA TECH CORP's (NASDAQ:AIRE) shares fell 13.02% to $0.97. In the last month the share price increased with 230.0%.
ADVB	-12.78%	ADVANCED BIOMED INC's (NASDAQ:ADVB) shares fell 12.78% to $0.49. Shareholders saw the stock price going 42.56% higher in the past month.
KAPA	-12.72%	There was a downturn in KAIROS PHARMA LTD's (NYSEARCA:KAPA) shares, as they experienced a 12.72% decline, closing at $1.17 during Friday's session. Yesterday the company had a press release: Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of ENV105 in Advanced Prostate Cancer with Median Progression Free Survival of Over One Year.

Our top losers page will show you the full list.